Frangioni Laboratory forms the discovery engine for the Beth Israel Deaconess Medical Center's (BIDMC) Center for Molecular Imaging. In this laboratory, new contrast agents and new imaging technologies are developed.
Longwood Small Animal Imaging Facility, directed by Dr. Frangioni, permits proof of principle for new discoveries. It also serves as a resource for the BIDMC and the entire research community of the Longwood Medical Area of Harvard Medical School.
The Translational Cancer Imaging Facility, also a part of the Center, will permit translation of novel imaging technology from the "bench to the bedside," with an emphasis on safety and efficiency.
Taken together, the Center aims to push the boundaries of what is possible in molecular imaging. Long-term goals include developing novel imaging technologies with sensitivity approaching the single cell limit and the development of high-throughput screening for disease-specific targeting ligands.
John V. Frangioni, MD, PhD
, is an attending physician and Professor in the Division of Hematology/Oncology, Department of Medicine, at the Beth Israel Deaconess Medical Center and a Professor of Radiology in the Department of Radiology . His academic appointments as Professor of Medicine and Professor of Radiology are at Harvard Medical School. His laboratory focuses on in vivo imaging technologies, including chemistry, detectors, and their fusion.